Table 1. Baseline Clinical and Imaging Characteristics, Treatment, and predictors of 3-month mRS.

	All patients (N=123)	mRS 0-2 (N=68)	mRS 3-6 (N=55)	P-value
Age	69.8±15.9	68.9±16.9	70.8±14.7	0.727*
Baseline NIHSSS	11(6–16)	7(5–11.5)	16(14–20.75)	<0.0001*
Female gender	55(44.7%)	31(45.6%)	24(43.6%)	0.973‡
Right hemisphere	74(47.2%)	34(50.0%)	24(43.6%)	0.602‡
Time to MRI	3:57±1:26	3:45±1:29	4:12±1:20	0.085†
DWI volume, mL	37.4±47.7	16.3±20.1	63.4±58.2	<0.0001*
MTT volume, mL	129.5±101.3	80.6±78.3	189.9±94.1	<0.0001*
Tmax volume, mL	148.1±114.9	89.5±86.5	217.3±106.0	<0.0001*
Absolute mismatch, mL	92.7±81.4	64.9±69.1	127.1±82.9	<0.0001*
Relative mismatch	8.7±21.6	10.9±27.8	6.0±8.8	0.541*
Reperfusion therapy	None: 37(30.1%)	22(32.4%)	15(25.4%)
	IV-TPA: 61(49.6%)	36(52.9%)	25(45.5%)	0.20‡
	IAT +/- IV-TPA: 25(20.3%)	10(14.7%)	15(27.3%)
Occlusion level	ICA: 24(19.5%)	6(8.8%)	18(32.7%)
	MCA M1: 39(31.7%)	15(22.1%)	24(43.6%)	<0.0001‡
	MCA M2/3: 36(29.3%)	24(35.3%)	12(21.8%)
	None: 24(19.5%)	23(33.8%)	1(1.8%)

^*Mann-Whitney U test.

^†Student's t-test.

^‡χ²-test.